J. Gilmer

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

D. Conrad, H. Bear, C. Camarena, 2019, BMC Immunology.